These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Anticoagulation and the cardioversion of atrial flutter. James PR; Hardman SM Int J Clin Pract; 2000; 54(1):5-6. PubMed ID: 10750250 [No Abstract] [Full Text] [Related]
6. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M; Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865 [TBL] [Abstract][Full Text] [Related]
7. Strategies for cardioversion of atrial fibrillation--time for a change? Silverman DI; Manning WJ N Engl J Med; 2001 May; 344(19):1468-70. PubMed ID: 11346813 [No Abstract] [Full Text] [Related]
8. Cardioversion of persistent atrial flutter in non-anticoagulated patients at low risk for thromboembolism. Bertaglia E; D'Este D; Franceschi M; Pascotto P Ital Heart J; 2000 May; 1(5):349-53. PubMed ID: 10832811 [TBL] [Abstract][Full Text] [Related]
9. Risk of thromboembolism in acute atrial fibrillation or atrial flutter. Stoddard MF Echocardiography; 2000 May; 17(4):393-405. PubMed ID: 10979012 [TBL] [Abstract][Full Text] [Related]
10. The optimal management of cardioversion of atrial fibrillation or flutter: still a 'stunning' problem. Stellbrink C; Hanrath P Eur Heart J; 2000 May; 21(10):795-8. PubMed ID: 10781349 [No Abstract] [Full Text] [Related]
12. Antithrombotic therapy in atrial fibrillation. Dunn M; Alexander J; de Silva R; Hildner F Chest; 1986 Feb; 89(2 Suppl):68S-74S. PubMed ID: 3510832 [No Abstract] [Full Text] [Related]
13. Safety of electrical cardioversion in patients with previous embolic events. Elhendy A; Gentile F; Khandheria BK; Bailey KR; Burger KN; Seward JB Mayo Clin Proc; 2001 Apr; 76(4):364-8. PubMed ID: 11322351 [TBL] [Abstract][Full Text] [Related]
14. Early cardioversion of atrial fibrillation and atrial flutter guided by transoesophageal echocardiography: a single centre 8.5-year experience. Corrado G; Santarone M; Beretta S; Tadeo G; Tagliagambe LM; Foglia-Manzillo G; Spata M; Miglierina E; Acquati F; Santarone M Europace; 2000 Apr; 2(2):119-26. PubMed ID: 11225938 [TBL] [Abstract][Full Text] [Related]
15. [Value of transesophageal echocardiography in the therapeutic management of non-valvular atrial fibrillation]. Baubion N Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1291-5. PubMed ID: 8952827 [TBL] [Abstract][Full Text] [Related]
16. Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter. Yadlapati A; Groh C; Passman R Am J Cardiol; 2014 Apr; 113(8):1362-3. PubMed ID: 24576547 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: A transesophageal echocardiographic study. Jaber WA; Prior DL; Thamilarasan M; Grimm RA; Thomas JD; Klein AL; Asher CR Am Heart J; 2000 Jul; 140(1):150-6. PubMed ID: 10874278 [TBL] [Abstract][Full Text] [Related]